Intrauterine Devices Market To Reach USD 10.5 Billion By 2032 | DataHorizzon Research
02 mai 2024 07h30 HE
|
DataHorizzon Research
Fort Collins, Colorado, May 02, 2024 (GLOBE NEWSWIRE) -- The growing popularity of intrauterine devices has fueled the industry's growth. A rising trend toward planned pregnancies is...
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
02 mai 2024 07h30 HE
|
Arbutus Biopharma Corporation
End-of-treatment data from two Phase 2a combination clinical trials with imdusiran to be presented at the EASL Congress in June 2024 Preliminary data from the single-dose portion of the AB-101-001...
Cancer Profiling Market To Reach USD 22.9 Billion By 2032 | DataHorizzon Research
02 mai 2024 07h00 HE
|
DataHorizzon Research
Fort Collins, Colorado, May 02, 2024 (GLOBE NEWSWIRE) -- The rise in the number of cancer cases worldwide pivots the industry growth. The growing incidence of cancer cases worldwide is a primary...
Plasmid DNA Manufacturing Market Size Expected to Reach USD 10.22 Bn by 2033
01 mai 2024 11h00 HE
|
Precedence Research
Ottawa, May 01, 2024 (GLOBE NEWSWIRE) -- The global plasmid DNA manufacturing market size is calculated at USD 2.18 billion in 2024, According to Precedence Research. Rising research on gene...
Aggregate Intellect Inc. Takes the Helm for Ladybug NutraTech's NutraBuddy AI Platform Development
01 mai 2024 10h36 HE
|
LadyBug Resource Group, Inc.
Aggregate Intellect Inc. Takes the Helm for Ladybug NutraTech's NutraBuddy AI Platform Development
WeightWatchers for Business and Personify Health Partner to Help Employers Address Weight Health Care
01 mai 2024 09h00 HE
|
WW International Inc.
NEW YORK and PROVIDENCE, R.I., May 01, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW), (“WeightWatchers,” “WW,” or the “Company”) today announced that WeightWatchers for Business is...
Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation
01 mai 2024 08h47 HE
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications ...
SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level
01 mai 2024 08h35 HE
|
SELLAS Life Sciences Group, Inc.
- The Company Filed IP Protection Related to the ASXL1 Mutation, a Highly Prevalent Gene Mutation in Myeloid Malignancies and Solid Tumors With Significant Market Potential – - 100% Overall...
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
01 mai 2024 08h31 HE
|
Neuronetics
MALVERN, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
IBN Announces From Lab to Launch Podcast Featuring Clene Inc. CEO Rob Etherington
01 mai 2024 08h30 HE
|
InvestorBrandNetwork (IBN)
LOS ANGELES, May 01, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies with the investment community, today announces that...